先进制造业知识服务平台
国家科技图书文献中心机械分馆  工信部产业技术基础公共服务平台  国家中小企业公共服务示范平台

OA期刊


ISSN1942-0862
刊名Mabs
出版商Taylor & Francis Inc.
urlhttps://www.tandfonline.com/loi/kmab20
机构Taylor & Francis Ltd.



全部

2010 2011 2012 2013 2014 2015
2016 2017 2018 2019 2020 2021
2022 2023 2024 2025

2025, vol.17, no.1 2025, vol.17, no.2 2025, vol.17, no.3 2025, vol.17, no.4

题名作者出版年年卷期
Analysis of how antigen mutations disrupt antibody binding interactions toward enabling rapid and reliable antibody repurposingSumaiya Islam;Varun M. Chauhan;Robert J. Pantazes;20252025, vol.17, no.1
Antibodies to watch in 2025Silvia Crescioli;Hélène Kaplon;Lin Wang;Jyothsna Visweswaraiah;Vaishali Kapoor;Janice M. Reichert;20252025, vol.17, no.1
Online native hydrophobic interaction chromatography-mass spectrometry of antibody-drug conjugatesTrevor Kempen;Lance Cadang;Yuchen Fan;Kelly Zhang;Tao Chen;Bingchuan Wei;20252025, vol.17, no.1
A bispecific antibody-drug conjugate targeting pCAD and CDH17 has antitumor activity and improved tumor-specificityAlyssa Synan;Nila C. Wu;Roberto Velazquez;Thomas Gesner;Claude Logel;Kathrin Mueller;Andrew Green;Patrizia Barzaghi-Rinaudo;Quincey Simmons;Samuele Mercan;Xingyi Shi;Xun Li;Vivek Sagar;Joshua Korn;Margaret McLaughlin;William R. Tschantz;Dominik Hainzl;Anthony Malamas;Thomas Huber;Regis Cebe;Kathleen T. Xie;Joseph A. D’Alessio;20252025, vol.17, no.1
Prediction of protein biophysical traits from limited data: a case study on nanobody thermostability through NanoMeltAubin Ramon;Mingyang Ni;Olga Predeina;Rebecca Gaffey;Patrick Kunz;Shimobi Onuoha;Pietro Sormanni;20252025, vol.17, no.1
Engineered ipilimumab variants that bind human and mouse CTLA-4Brett Robison;SJ Diong;Anusha Kumar;Thomas M. Moon;Olin Chang;Bryant Chau;Christine Bee;Ishita Barman;Arvind Rajpal;Alan J. Korman;Sean West;Pavel Strop;Peter S. Lee;20252025, vol.17, no.1
Predicting purification process fit of monoclonal antibodies using machine learningAndrew Maier;Minjeong Cha;Sean Burgess;Amy Wang;Carlos Cuellar;Soo Kim;Neeraja Sundar Rajan;Josephine Neyyan;Rituparna Sengupta;Kelly O’Connor;Nicole Ott;Ambrose Williams;20252025, vol.17, no.1
With great power, comes great responsibility: the importance of broadly measuring Fc-mediated effector function early in the antibody development processSilvia Crescioli;Shashi Jatiani;Lenny Moise;20252025, vol.17, no.1
Cost and supply considerations for antibody therapeuticsChun Chen;Zoe Garcia;David Chen;Hong Liu;Piper Trelstad;20252025, vol.17, no.1
Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC studyJennifer Moore;Alicia Aylott;Wen-Hung Chen;Jerzy Daniluk;Ian A. Hawes;Sergio Parra;Prosenjit Sarkar;Yasmin Sanchez-Pearson;Megan Turner;Amanda Peppercorn;Andrew Skingsley;20252025, vol.17, no.1
12